Biotechnology, International Law, and the National Interest

Extract

On November 25, 1969 Richard Nixon announced that because of the “massive, unpredictable, and potentially uncontrollable consequences” of biological weapons, the United States would never use these weapons, would destroy all existing stocks, and would confine its research to strictly defined measures of defense (Harris, 1987:193). This unilateral renunciation followed an extensive review by the National Security Council of U.S. chemical and biological warfare policy, which lasted six months and involved every relevant agency in the U.S. government and which concluded that U.S. biological warfare capabilities provided no compelling military advantages (Tucker, 1984-85:61). Three years later the Biological and Toxin Weapons Convention (BWC) was signed; it was the first postwar arms control agreement to elminate an entire class of weapons from the arsenals of states (U.S. Arms Control and Disarmament Agency, 1982:122). The treaty was ratified unanimously by the U.S. Senate in 1974, and over 100 nations have acceded to it. This arms control achievement has been attributed in part to the serious doubts which many countries, including the United States, shared about the military value of biological weapons (Harris, 1987:205-6). Within a decade of the signing of this treaty, however, the development of recombinant-DNA (deoxyribonucleic acid) technology had raised the possibility of a new and more effective form of biological warfare.